Zambia : Why is Zambia using a vaccine rejected by South Africa because of low efficacy?

Reaction to the Second Wave
Following South Africa’s devastating second wave, Health Minister Zweli Mkize announced that South Africa had secured 1.5-million doses of the Oxford/AstraZeneca COVID vaccine.This decision came amidst growing public pressure for South Africa to begin its national vaccine roll-out, ahead of vaccine doses secured through the international procurement mechanism, COVAX. At the time, a big factor considered by the health department was which companies could deliver doses immediately, given the limited stock availability due to high global demand for the jabs, Health Minister Zweli Mkhize said during a televised address.
Whilst in Zambia, Chief Spokesperson Dora Siliya announced that Government had approved Zambia’s participation in the free COVAX facility program to vaccinate 40% of the country’s population.

Related Keywords

South Africa ,India ,Zambia ,Zambians ,South African ,Zweli Mkize ,Barry Schoub ,Benjamin Kagina ,Oxford Astrazeneca ,Dora Siliya ,Zweli Mkhize ,Astrazeneca ,Health Chitalu Chilufya ,Serum Institute Of India ,Vaccines For Africa Initiative ,December The ,Health Minister Zweli Mkize ,Health Minister Zweli Mkhize ,Chief Spokesperson Dora Siliya ,Serum Institute ,Africa Initiative ,Evidence Based Data ,இந்தியா ,சாம்பியா ,டோரா சீலியா ,சீரம் நிறுவனம் ஆஃப் இந்தியா ,டிசம்பர் தி ,சீரம் நிறுவனம் ,